1
Fog Pharma
Oncology
HBM contact: Dr Emil Bujak
Company status: private
FogPharma’s
cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can
drug targets beyond the reach of conventional therapeutics.
Oncology
HBM contact: Dr Emil Bujak
Company status: private
FogPharma’s
cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can
drug targets beyond the reach of conventional therapeutics.